Do we need to adjust for interim analyses in a Bayesian adaptive trial design?

Elizabeth Ryan(Cancer Research And Biostatistics), Daniel Slade(Temple University), Kristian Brock(Cancer Research UK Clinical Trials Unit), Simon Gates(Oxford Brookes University)
BMC Medical Research Methodology
June 10, 2020
Cited by 50


Related Papers